NCT06104852Recruiting
Triage Survey for Neurology Research Eligibility
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 18 Oct 2023
- Start date
- 2 Jun 2023
- Primary completion date
- 2 Jun 2027
- Lead sponsor
- Adams Clinical
- Diseases
- Alzheimer disease
- NCT number
- NCT06104852
What you commit to
- Study type: Observational
- Planned participants: 600
- From 2 Jun 2023 to the primary completion date, 2 Jun 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Moderate or severe substance use disorder within 90 days prior to screening, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
Other illness
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
Other
- Participant lacks the language skills or cognitive ability to understand the screening process.
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Currently employed by Adams Clinical or a first-degree relative of an employee working on this study.
Who the study is looking for
- Participant and study partner (when applicable) have signed an ICF prior to study-specific procedures being performed.
- Participant and study partner (when applicable) are at least 18 years old.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Copley Clinical Coordinator of this site? Confirm its status | Boston | United States | Not yet recruiting |
| Berman Clinical Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| Adams Clinical Coordinator of this site? Confirm its status | Watertown | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.